ClinConnect ClinConnect Logo
Search / Trial NCT05510401

Evaluation of Safe Use of SECURIDRAP® SELFIA®

Launched by GROUPE MULLIEZ-FLORY · Aug 18, 2022

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Disorientation Nocturnal Behavioral Disorders Major Cognitive Impairment

ClinConnect Summary

This clinical trial is studying the safety of a special type of bedding called SECURIDRAP® SELFIA®, which is designed for patients who may experience confusion, cognitive difficulties, or behavioral issues. The trial is taking place in nine medical facilities in France and aims to ensure that this updated version of the bedding is safe for use. Researchers will closely monitor participants for any unwanted side effects while using the bedding.

To be eligible for the trial, participants must be at least 18 years old and have a doctor’s prescription for the SECURIDRAP® SELFIA®. They should also have some level of disorientation or cognitive impairment, be at risk of falling from bed, and be under guardianship if needed. Participants will need to provide their agreement to take part in the study. Throughout the trial, participants can expect to be closely observed for their safety and comfort while using the bedding. It's important to note that certain individuals, like those with severe agitation or who are currently involved in other clinical studies, cannot participate.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Patient at least 18 years old
  • Patient having a medical prescription for SÉCURIDRAP® SELFIA®
  • Patient in phase or state of disorientation
  • Patient with nocturnal behavior disordre
  • Patient with major cognitive impairment
  • Patient at risk of falling into bed
  • Patient subject to guardianship or curatorship
  • Patient beneficiary or affiliated to a social security scheme
  • Patient who has given their participation agreement aand informed consent
  • Exclusion Criteria:
  • Patient and/or guardianship or curatorship refusing to agree to participate in the clinical investigation
  • Patient in psychiatry
  • Patient with severe agitation
  • Patient who will be agitated once installed in the SÉCURIDRAP® SELFIA®
  • Patient with intolerance to the medical device
  • Patient able to extract himself from SÉCURIDRAP® SELFIA®
  • Patient able to unlock the bed rails by himself
  • Patient without social coverage or not benefiting from it through a third party
  • Patient minor, pregnant woman, persons deprived of their liberty
  • Patient who participating or having participated in another clinical investigation, drug or medical device in the 30 days preceding inclusion

About Groupe Mulliez Flory

Groupe Mulliez-Flory is a distinguished clinical trial sponsor dedicated to advancing healthcare through innovative research and development. With a focus on improving patient outcomes, the organization collaborates with leading medical professionals and institutions to conduct rigorous clinical trials across various therapeutic areas. Committed to ethical practices and regulatory compliance, Groupe Mulliez-Flory prioritizes patient safety and data integrity while striving to bring novel therapies to market. Their expertise and dedication position them as a key player in the clinical research landscape, fostering breakthroughs that enhance the quality of life for patients worldwide.

Locations

Rennes, , France

Lille, , France

Lyon, , France

Lille, Nord, France

Bailleul, , France

Bully Les Mines, , France

Hazebrouck, , France

Le Quesnoy, , France

Limoux, , France

Roubaix, , France

Saint Jean Delnous, , France

Patients applied

0 patients applied

Trial Officials

François Pr PUISIEUX

Principal Investigator

CHU Lille

Aline Dr CORVOL

Principal Investigator

CHU Rennes

Sabine Dr AHMINE

Principal Investigator

Hospices Civils de Lyon

Thierry Dr LECRIQUE

Principal Investigator

CSSR La Clauze

Brigitte Dr GERS

Principal Investigator

USSAP- ASM LIMOUX

Marguerite Dr REY

Principal Investigator

USSAP- ASM LIMOUX

Valérie Dr WIEL

Principal Investigator

EHPAD l'Aquarelle

Brigitte Dr TILMONT

Principal Investigator

CMMF de Bailleul

Eddy Dr BAHEU

Principal Investigator

CH Hazebrouck

Denis Dr LEFEBVRE

Principal Investigator

CH Le Quesnoy

Philippe Dr VEAU

Principal Investigator

CSSR La Clauze

Pearlide Dr Kizonzolo-de-Bello

Principal Investigator

CHG Roubaix

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials